Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01984775 · ClinicalTrials.gov registry record · Phase 1
A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects
A Phase 1 study, sponsored by Stiefel, a GSK Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 52
- Enrollment target
NCT01984775 is a Phase 1 study that has completed, run by Stiefel, a GSK Company. The registered enrollment target is 52 participants.
The verdict
NCT01984775, a Phase 1 study, has completed, sponsored by Stiefel, a GSK Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 52 participants
- Enrollment target
Study Summary
This study is conducted to assess the potential of topically-applied GSK2894512 cream at 3 concentrations (0.5%, 1%, and 2%) to induce skin irritation at the site of application in healthy subjects. Results from this study will be considered when selecting the concentration(s) of GSK2894512 to evaluate in the Phase II and Phase III clinical safety and efficacy studies. Approximately 40 subjects will be enrolled in order to have at least 30 evaluable subjects complete the study. The total duration of subject participation may be up to 50 days.
Interventions
- DRUG Vehicle cream
- DRUG GSK2894512 cream
- DRUG Positive control
- DRUG Negative control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2013-10-30 |
| Est. Completion | 2014-07-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01984775
The ClinicalTrials.gov registry entry for NCT01984775 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stiefel, a GSK Company, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vehicle cream is the first listed.
NCT01984775 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01984775 about?
NCT01984775 is a clinical study titled "A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects". This study is conducted to assess the potential of topically-applied GSK2894512 cream at 3 concentrations (0.5%, 1%, and 2%) to induce skin irritation at the site of application in healthy subjects. Results from this study will be considered when selecting the concentration(s) of GSK2894512 to evalu...
What is the current status of trial NCT01984775?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 52 participants. The study started on 2013-10-30. Estimated completion is 2014-07-02.
What interventions are being tested in trial NCT01984775?
The interventions under investigation include: Vehicle cream (DRUG), GSK2894512 cream (DRUG), Positive control (DRUG), Negative control (DRUG).
Who is sponsoring clinical trial NCT01984775?
This trial is sponsored by Stiefel, a GSK Company, which has 37 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.